Current Research in Translational Medicine

Papers
(The TQCC of Current Research in Translational Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation23
Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era21
Performances of the H-score and the HLH-2004 score in the positive diagnosis of secondary hemophagocytic lymphohistiocytosis18
Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFC18
Editorial board17
Association of Normal and Mutated APOL1 G2 Rs60910145 alleles with SCD, Body Mass Index, and Renal Function Biomarkers and Indices15
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies14
A novel MPIG6B gene mutation in an adolescent girl with congenital thrombocytopenia and myelofibrosis13
Lactate level is an independent predictor of mortality in patients with hematologic malignancy receiving urgent chemotherapy in intensive care unit12
Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience11
Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death11
Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease9
CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis9
Editorial board9
Editorial board8
Cytogenetics in the management of hematological malignancies: An overview of alternative technologies for cytogenetic characterization7
WITHDRAWN: Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetic body to induce macrophage polarization and inhibit erythrocyte damage7
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation7
Editorial board7
Optimizing CAR-T cell function in solid tumor microenvironment: insights from culture media additives7
Construction of a stromal-related prognostic model in acute myeloid leukemia by comprehensive bioinformatics analysis7
Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantati6
Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH)6
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization a6
mRNA-lncRNA gene expression signature for predicting pediatric AML relapse6
Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports6
Contents5
Letter to the editor regarding “Bone mineral density, osteopenia, osteoporosis, and fracture risk in patients with atopic dermatitis: A systematic review and meta-analysis”5
Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation5
AI-assisted computational screening and docking simulation prioritize marine natural products for small-molecule PCSK9 inhibition5
Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression5
Editorial board4
Thanks to reviewers4
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)4
Contents4
Exosomal miR-195 in hUC-MSCs alleviates hypoxia-induced damage of trophoblast cells through tissue factor pathway inhibitor 24
Contents4
Exploring clues pointing toward the existence of a brain-gut microbiota-hair follicle axis4
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations4
Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review4
Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells4
Caspases in PANoptosis4
Editorial board3
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set3
Allogeneic hematopoietic stem cell transplantation in 18 patients with atypical inherited bone marrow failure syndromes: Efficacy and long-term outcomes3
Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation3
Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)3
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)3
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice3
FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia3
Contents3
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia3
Clinical image: A new category of articles in current research in translational medicine3
The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical a3
Extracorporeal membrane oxygenation (ECMO) during aplasia: A bridge towards myopericarditis recovery after autologous hematopoietic stem cell transplant for systemic sclerosis and recent Coronarovirus3
0.073414087295532